small molecule

BETAXON

LEVOBETAXOLOL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity

CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand name	BETAXON
Active ingredient	LEVOBETAXOLOL HYDROCHLORIDE
Strength	EQ 0.5% BASE
Dosage form	SUSPENSION/DROPS
Route	OPHTHALMIC
Modality	Small molecule
FDA approval	February 2000
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.